272 related articles for article (PubMed ID: 37428429)
1. Pathophysiology and Treatment Opportunities of Iron Deficiency in Heart Failure: Is There a Need for Further Trials?
Tkaczyszyn M; Fudim M; Ponikowski P; Biegus J
Curr Heart Fail Rep; 2023 Aug; 20(4):300-307. PubMed ID: 37428429
[TBL] [Abstract][Full Text] [Related]
2. Iron Deficiency, Anemia, and Iron Supplementation in Patients With Heart Failure: A Population-Level Study.
Wahid M; Islam S; Sepehrvand N; Dover DC; McAlister FA; Kaul P; Ezekowitz JA
Circ Heart Fail; 2024 Apr; 17(4):e011351. PubMed ID: 38572652
[TBL] [Abstract][Full Text] [Related]
3. Role of Iron Therapy in Heart Failure: A Consensus Statement from India.
Chopra HK; Wander GS; Nair T; Ponde CK; Nanda NC; Narula J; Ray S; Venugopal K; Iyengar SS; Kasliwal RR; Chandra P; Prakash S; Bansal S; Rana DS; Kerkar P; Dasbiswas A; Sawhney J; Shanmungasundram S; Kumar V; Vijayalakshmi IB; Pancholia AK; Sharma V; Kapoor A; Swami OC; Isser HS; Rastogi V; Arora YK; Omar AK; Sathe S; Rajput R; Prabhakar D; Paul GJ; Jagia P; Malhotra P; Suryaprakash G; Mittal V; Jagia M; Jabir A; Mishra SS; Routray SN; Sinha AK; Bhargava M; Mahmood K; Bhatia M; Kalra P; Katyal VK; Tandon R; Grover R; Chhabra A; Shastry NR
J Assoc Physicians India; 2023 Mar; 71(3):11-12. PubMed ID: 37354511
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure.
Ponikowski P; Kirwan BA; Anker SD; Dorobantu M; Drozdz J; Fabien V; Filippatos G; Haboubi T; Keren A; Khintibidze I; Kragten H; Martinez FA; McDonagh T; Metra M; Milicic D; Nicolau JC; Ohlsson M; Parhomenko A; Pascual-Figal DA; Ruschitzka F; Sim D; Skouri H; van der Meer P; Jankowska EA
Eur J Heart Fail; 2019 Dec; 21(12):1651-1658. PubMed ID: 31883356
[TBL] [Abstract][Full Text] [Related]
5. Parenteral Iron in Heart Failure: An Indian Perspective.
Sathyamurthy I; Swami OC
J Assoc Physicians India; 2022 Feb; 70(2):11-12. PubMed ID: 35436828
[TBL] [Abstract][Full Text] [Related]
6. Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish Heart Failure Registry.
Becher PM; Schrage B; Benson L; Fudim M; Corovic Cabrera C; Dahlström U; Rosano GMC; Jankowska EA; Anker SD; Lund LH; Savarese G
Eur J Heart Fail; 2021 Nov; 23(11):1844-1854. PubMed ID: 34476878
[TBL] [Abstract][Full Text] [Related]
7. Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis.
Filippatos G; Ponikowski P; Farmakis D; Anker SD; Butler J; Fabien V; Kirwan BA; Macdougall IC; Metra M; Rosano G; Ruschitzka F; van der Meer P; Wächter S; Jankowska EA;
Circulation; 2023 May; 147(22):1640-1653. PubMed ID: 37051919
[TBL] [Abstract][Full Text] [Related]
8. Iron deficiency in chronic and acute heart failure: A contemporary review on intertwined conditions.
Cunha GJL; Rocha BML; Menezes Falcão L
Eur J Intern Med; 2018 Jun; 52():1-7. PubMed ID: 29680173
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis.
Ponikowski P; Mentz RJ; Hernandez AF; Butler J; Khan MS; van Veldhuisen DJ; Roubert B; Blackman N; Friede T; Jankowska EA; Anker SD
Eur Heart J; 2023 Dec; 44(48):5077-5091. PubMed ID: 37632415
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of intravenous and oral iron supplements for the treatment of iron deficiency in patients with heart failure: A network meta-analysis of randomized controlled trials.
Mei Z; Chen J; Luo S; Jin L; Liu Q; Chen Y
Pharmacol Res; 2022 Aug; 182():106345. PubMed ID: 35810949
[TBL] [Abstract][Full Text] [Related]
11. Neglected Comorbidity of Chronic Heart Failure: Iron Deficiency.
Manceau H; Ausseil J; Masson D; Feugeas JP; Sablonniere B; Guieu R; Puy H; Peoc'h K
Nutrients; 2022 Aug; 14(15):. PubMed ID: 35956390
[TBL] [Abstract][Full Text] [Related]
12. Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial.
Metra M; Jankowska EA; Pagnesi M; Anker SD; Butler J; Dorigotti F; Fabien V; Filippatos G; Kirwan BA; Macdougall IC; Rosano G; Ruschitzka F; Tomasoni D; van der Meer P; Ponikowski P;
Eur J Heart Fail; 2022 Oct; 24(10):1928-1939. PubMed ID: 35869741
[TBL] [Abstract][Full Text] [Related]
13. Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalization: a European multinational economic evaluation.
McEwan P; Harrison C; Binnie R; Lewis RD; Cohen-Solal A; Lund LH; Ohlsson M; von Haehling S; Comin-Colet J; Pascual-Figal DA; Wächter S; Dorigotti F; de Arellano AR; Ponikowski P; Jankowska EA
Eur J Heart Fail; 2023 Mar; 25(3):389-398. PubMed ID: 36718652
[TBL] [Abstract][Full Text] [Related]
14. Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial.
Rosano G; Ponikowski P; Vitale C; Anker SD; Butler J; Fabien V; Filippatos G; Kirwan BA; Macdougall IC; Metra M; Ruschitzka F; Kumpeson V; Goehring UM; van der Meer P; Jankowska EA;
Cardiovasc Diabetol; 2023 Aug; 22(1):215. PubMed ID: 37592272
[TBL] [Abstract][Full Text] [Related]
15. [The Effects of Therapy for Iron Deficiency in Patients With Different Etiologies of Heart Failure and Concomitant Diseases].
Uskach TM; Tereschenko SN
Kardiologiia; 2023 Dec; 63(11):87-95. PubMed ID: 38088117
[TBL] [Abstract][Full Text] [Related]
16. Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and Design.
Mentz RJ; Ambrosy AP; Ezekowitz JA; Lewis GD; Butler J; Wong YW; De Pasquale CG; Troughton RW; O'Meara E; Rockhold FW; Garg J; Samsky MD; Leloudis D; Dugan M; Mundy LM; Hernandez AF;
Circ Heart Fail; 2021 May; 14(5):e008100. PubMed ID: 34003690
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Iron Deficiency in Heart Failure.
Shamsi A; Cannata A; Piper S; Bromage DI; McDonagh TA
Curr Cardiol Rep; 2023 Jul; 25(7):649-661. PubMed ID: 37329419
[TBL] [Abstract][Full Text] [Related]
18. [Expert consensus regarding treatment of iron deficiency in stable and decompensated patients with heart failure].
Mareev YV; Gilarevsky SR; Begrambekova YL; Lopatin YM; Garganeeva AA; Duplyakov DV; Kobalava ZD; Golukhova EZ; Koziolova NA; Panov АV; Lelyavina ТА; Drapkina OM; Mareev VY
Kardiologiia; 2021 May; 61(4):73-78. PubMed ID: 33998412
[TBL] [Abstract][Full Text] [Related]
19. Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function.
Macdougall IC; Ponikowski P; Stack AG; Wheeler DC; Anker SD; Butler J; Filippatos G; Göhring UM; Kirwan BA; Kumpeson V; Metra M; Rosano G; Ruschitzka F; van der Meer P; Wächter S; Jankowska EA
Clin J Am Soc Nephrol; 2023 Sep; 18(9):1124-1134. PubMed ID: 37382961
[TBL] [Abstract][Full Text] [Related]
20. Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial.
Filippatos G; Farmakis D; Colet JC; Dickstein K; Lüscher TF; Willenheimer R; Parissis J; Gaudesius G; Mori C; von Eisenhart Rothe B; Greenlaw N; Ford I; Ponikowski P; Anker SD
Eur J Heart Fail; 2013 Nov; 15(11):1267-76. PubMed ID: 23787722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
